about
Second-stage labor duration in nulliparous women: relationship to maternal and perinatal outcomesPrevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproateWork-up of stillbirth: a review of the evidenceIn utero tobacco exposure epigenetically modifies placental CYP1A1 expressionRobust estimation of fetal heart rate variability using Doppler ultrasound.Influenza-like illness in hospitalized pregnant and postpartum women during the 2009-2010 H1N1 pandemic.The challenge of cross-cultural clinical trials research: case report from the Tibetan Autonomous Region, People's Republic of China.Vitamins C and E to prevent complications of pregnancy-associated hypertensionPatient-level analysis of outcomes using structured labor and delivery dataA randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsyA multicenter, randomized trial of treatment for mild gestational diabetes.Timing of elective repeat cesarean delivery at term and neonatal outcomes.Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trialThe obstetric and neonatal implications of a low value on the 50-g glucose screening testRelationship between 1-hour glucose challenge test results and perinatal outcomes.Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals.The effect of active and passive household cigarette smoke exposure on pregnant women with asthma.The effect of maternal body mass index on neonatal outcome in women receiving a single course of antenatal corticosteroids.Cost-effectiveness of trial of labor after previous cesarean in a minimally biased cohort.The effect of body mass index on therapeutic response to bacterial vaginosis in pregnancy.White's classification of maternal diabetes and vaginal birth after cesarean delivery success in women undergoing a trial of labor.Adverse pregnancy outcomes among women with prior spontaneous or induced abortionsTiming of delivery and adverse outcomes in term singleton repeat cesarean deliveries.Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery.Relationship between fetal station and successful vaginal delivery in nulliparous womenHaptoglobin phenotype and abnormal uterine artery Doppler in a racially diverse cohort.Intrapartum magnesium sulfate and the potential for cardiopulmonary drug-drug interactions.Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomesRisk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study.Frequency of and factors associated with severe maternal morbidityInadequate weight gain in overweight and obese pregnant women: what is the effect on fetal growth?Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery.Can differences in obstetric outcomes be explained by differences in the care provided? The MFMU Network APEX study.Perfluorochemicals and endometriosis: the ENDO study.Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus.Delivery timing and cesarean delivery risk in women with mild gestational diabetes mellitus.Maternal and neonatal outcomes of repeat cesarean delivery in women with a prior classical versus low transverse uterine incision.Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trialEpilepsy in pregnancy.Neonatal outcomes in twin pregnancies delivered moderately preterm, late preterm, and term.
P50
Q24648089-948CAF39-510C-4BFA-9034-C94A8013392EQ28178563-E2DCD972-58C0-4630-BAB4-370C9D126CA3Q28389394-A9A1AAE4-29EF-4A46-8C74-800ABEB647D5Q28749684-CCF29C44-7D71-4C7A-84AD-08195C7625C2Q30333245-AA19DB99-A95E-4B9A-A792-F49AB547A9AEQ30406291-842D325B-D93C-4096-8AC1-B2F773360144Q33225114-3C28B730-FFF8-480C-AB08-41DE15E47879Q33389072-4594109D-E915-4541-9BF1-1B1B2D3D7B5BQ33470070-147E2261-F634-4E88-B040-5EA03A26711CQ33577192-C7FB00DA-555B-4683-B78A-ACFC34C16112Q33583959-BBFA34C5-C684-41C2-88B6-62DDBFAB2700Q33611728-14D3EF19-C698-4158-A717-831E6026862EQ33618715-7C2383E2-AA52-44D6-97FC-027BE806335EQ33618977-D35F52EF-8029-4FCF-A697-16621CE4816AQ33642344-736A87EA-CE97-4909-B95A-CE25DAB7B73EQ33649152-EC21B45D-6639-4811-B37E-680DAF8A008AQ33706622-96EC1C08-C34A-403F-91FA-C1A9D352FFB1Q33712500-E9BFCA82-F907-4E89-8D25-0DEC83F3DBAAQ33724823-FA9876DE-66EA-4E91-846A-C3EFC6EAA658Q33738804-84DFCFD8-F30D-484E-8830-9D51B7140E03Q33748754-CB30AC83-4823-41A7-8828-206EF9F5CB67Q33769849-178B6F49-C0A3-4C57-B55F-1E90F3B93082Q33788088-775ADC6D-F79B-43A3-802D-EFC36664ACA6Q33827493-709318E3-44E6-4249-8ED4-43D035ABDC83Q33881085-687C4B44-3F52-4BA5-86CE-C91B49ABC238Q33896045-90B92103-EE9E-4201-BE9E-A88917723BFFQ33911412-567B5DAC-9142-465D-A0CC-16B52BB8CC75Q33916601-AAE0092F-4C3A-4DBC-BA30-29129AF0BB90Q33965258-A3C5C98A-8863-4CFA-9F1D-3542A67DBAD3Q33974882-A9623707-3737-4911-B488-0A81E1639AE1Q33983212-301FAB02-5030-41E5-8D77-DEB2850CBA7DQ33983805-A11C6249-FE12-4E45-89A8-05753755F356Q33984402-DA399653-F208-4220-9E20-29F1F4E3A011Q34004281-E36F45F2-D5FA-4E81-B7EF-1F664227BE53Q34088813-EDF4ECC1-63B0-4335-81D3-4DA3232D4098Q34111449-7786FCF5-A848-47AF-9866-35964AA39C0EQ34200396-F035ACB0-56D9-4E44-BDAB-5F5F15219824Q34330415-308D4243-BB65-40D3-B36C-023E4A8CD4DFQ34337718-66CDB9BB-B4BE-40F9-93EE-D77E87CFAB78Q34343324-F6CD90D1-05F5-4F14-A712-3E3FC83B23AE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael W Varner
@es
Michael W Varner
@nl
Michael W Varner
@sl
Michael W. Varner
@en
type
label
Michael W Varner
@es
Michael W Varner
@nl
Michael W Varner
@sl
Michael W. Varner
@en
prefLabel
Michael W Varner
@es
Michael W Varner
@nl
Michael W Varner
@sl
Michael W. Varner
@en
P1053
K-9890-2013
P106
P1153
35395177900
P21
P31
P3829
P496
0000-0001-9455-3973